AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Wuhan High Myopia Study

Recruitingn/aAges 18 Years - 65 YearsAllRenmin Hospital of Wuhan University
💬

In plain words

What the trial is, and whether it could suit you

The study aims to observe the long-term changes of ocular(especially fundus) structure and visual function in patients with high myopia, so as to provide evidence for the prevention, diagnosis and prognosis of high myopia.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Voluntarily sign informed consent; * Commit to follow the research procedures and cooperate with the whole process of the study; * Age ≥18 years old; * Best corrected visual acuity ≥0.1; * Spherical Equivalent Refraction≤-6.00D or axial length ≥26mm in high myopia group; Exclusion Criteria: * Unable or unwilling to sign informed consent; * Unable to cooperate with the examination; * Astigmatism ≤-1.5D; * Patients with refractive interstitial opacity so that fundus images cannot be collected; * Patients with fundus diseases such as diabetic retinopathy, hypertensive retinopathy, age-related macular degeneration, retinal vein obstruction, retinal artery obstruction, etc
💊

What it tests

  • observational
📍

Where

1 site
Renmin Hospital of Wuhan University
Wuhan, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy